Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukino, K.
Right arrow Articles by Eng, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukino, K.
Right arrow Articles by Eng, C.
[Cancer Research 64, 7231-7236, October 15, 2004]
© 2004 American Association for Cancer Research


Advances in Brief

Combined Total Genome Loss of Heterozygosity Scan of Breast Cancer Stroma and Epithelium Reveals Multiplicity of Stromal Targets

Koichi Fukino1,2,3, Lei Shen6, Satoshi Matsumoto2,3, Carl D. Morrison1,3,5, George L. Mutter7 and Charis Eng1,2,3,4,8

1 Clinical Cancer Genetics Program, 2 Human Cancer Genetics Program, Comprehensive Cancer Center, 3 Division of Human Cancer Genetics, Department of Molecular Virology, Immunology, and Medical Genetics, 4 Division of Human Genetics, Department of Internal Medicine, 5 Department of Pathology, College of Medicine, and 6 Division of Epidemiology and Biometrics, School of Public Health, The Ohio State University, Columbus, Ohio; 7 Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts; and 8 Cancer Research UK Human Cancer Genetics Research Group, University of Cambridge, Cambridge, United Kingdom

Recent breast cancer studies have highlighted the importance of interactions between cancer epithelium and tumor stroma. Recently, the focus of solid tumor investigations has shifted from mutations in carcinomatous epithelium to disturbances of tissue organization in cancer. The genetic basis of this microenvironment, however, remains to be clarified. To begin to resolve this problem, a total genome loss of heterozygosity (LOH) scan was done on epithelial and stromal DNA from 134 sporadic invasive breast carcinomas. In addition to detecting more frequent LOH at three loci in stroma than in epithelium, we found strong evidence that LOH frequencies were significantly elevated in specific regions of each chromosome. We detected 57 markers, which were preferentially lost either in stroma (n = 38) or epithelium (n = 19), relative to the background LOH frequencies on their respective chromosomes. This multiplicity of stromal cell LOH, and hence loss of genetic material, provides a possible mechanism for interpatient variation in host-stromal response to invading adenocarcinoma cells. This is consistent with a model in which initial, random LOH occurs equally among epithelium and stroma, but subsequent clonal selection is driven by factors, which appear to be distinctly different between malignant epithelial and surrounding stromal cells. Genetic alterations in stroma did not mimic those in epithelium, but they could play a different and parallel role in carcinogenesis and tumor progression, probably by modifying some features specific to breast cancer.




This article has been cited by other articles:


Home page
JAMAHome page
G. Assie, T. LaFramboise, P. Platzer, and C. Eng
Frequency of Germline Genomic Homozygosity Associated With Cancer Cases
JAMA, March 26, 2008; 299(12): 1437 - 1445.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. J. Trimboli, K. Fukino, A. de Bruin, G. Wei, L. Shen, S. M. Tanner, N. Creasap, T. J. Rosol, M. L. Robinson, C. Eng, et al.
Direct Evidence for Epithelial-Mesenchymal Transitions in Breast Cancer
Cancer Res., February 1, 2008; 68(3): 937 - 945.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Patocs, L. Zhang, Y. Xu, F. Weber, T. Caldes, G. L. Mutter, P. Platzer, and C. Eng
Breast-Cancer Stromal Cells with TP53 Mutations and Nodal Metastases
N. Engl. J. Med., December 20, 2007; 357(25): 2543 - 2551.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
K. Fukino, L. Shen, A. Patocs, G. L. Mutter, and C. Eng
Genomic Instability Within Tumor Stroma and Clinicopathological Characteristics of Sporadic Primary Invasive Breast Carcinoma
JAMA, May 16, 2007; 297(19): 2103 - 2111.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
F. Weber, Y. Xu, L. Zhang, A. Patocs, L. Shen, P. Platzer, and C. Eng
Microenvironmental Genomic Alterations and Clinicopathological Behavior in Head and Neck Squamous Cell Carcinoma
JAMA, January 10, 2007; 297(2): 187 - 195.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. J. Pelham, L. Rodgers, I. Hall, R. Lucito, K. C. Q. Nguyen, N. Navin, J. Hicks, D. Mu, S. Powers, M. Wigler, et al.
Identification of alterations in DNA copy number in host stromal cells during tumor progression
PNAS, December 26, 2006; 103(52): 19848 - 19853.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Sonnenschein and A. M. Soto
Are Times a' Changin' in Carcinogenesis?
Endocrinology, January 1, 2005; 146(1): 11 - 12.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.